IMPACT OF ICH Q8, Q9 QND Q10:
Quality by Design. Fact or Fiction

A joint meeting of RPSGB and PASG

Thursday 23rd April 2009

Royal Pharmaceutical Society, London

ICH Q8, Q9, Q10, design space, risk analysis and PAT threaten to revolutionise how the Pharmaceutical Industry works. Yet there seems to be a real lack of understanding of what is really expected from them and no obvious evidence that they are yet actually changing industry. This meeting put these initiatives into context, explained how they function and provided some practical examples.

Final Programme

PJ Report

Full report

Speakers' slides